The plant will use a patented process that incorporates carbon dioxide captured from energy generation emissions, aligning with sustainability goals and meeting the growing demand from pharmaceutical companies for high-grade sodium bicarbonate used in medicines and haemodialysis. Shares of Tata Chemicals Ltd ended at ₹1,068.80, down by ₹27.70, or 2.53%, on the BSE.
